PII has a broad knowledge and technical experience
in the formulation development and manufacture of a wide range of pharmaceutical
products. PII is able to provide clients with a wide range of options
to develop small molecules into quality pharmaceutical products including
several in-house drug development technologies. [Link
to DDS site]. The key to our success is being able to provide a flexible
approach for the client whether it is a step by step approach to development
work or simply the transfer of a product into development at late stage.
Over the years PII has worked with over 400 NCE small having a range of physico-chemical characteristics such as:
- poorly aqueous soluble drugs by formulating into solutions; lipid based or micro/nano emulsions to improve solubility
- highly potent and cytotoxic drugs
Preformulation protocols are designed to meet each client’s requirements.
Pharmaterials, a PII company in Reading, UK, provides many of these services for our clients in Europe and the USA. Click here for further information.
Pre-Formulation Services
|
|
Dosage Forms
|
|
PII’s Hunt Valley facilities are DEA registered to handle schedule I to V controlled substances.